机译:Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'
CHU Henri Mondor, AP HP, French Referral Ctr Cardiac Amyloidosis, Amyloidosis Mondor Network,GRC;
Pfizer Inc, New York, NY USA;
Stanford Univ, Sch Med, Stanford, CA 94305 USA;